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Lipotoxicity is a metabolic stress response impli-
cated in the pathogenesis of diabetes complications
and has been shown to involve lipid-induced oxida-
tive stress. To elucidate the molecular mechanisms
of lipotoxicity, we used retroviral promoter trap
mutagenesis to isolate a cell line that is resistant to
lipotoxic and oxidative stress. We show that loss of
three box C/D small nucleolar RNAs (snoRNAs) en-
coded in the ribosomal protein L13a (rpL13a) locus
is sufficient to confer resistance to lipotoxic and
oxidative stress in vitro and prevents the propagation
of oxidative stress in vivo. Our results provide
evidence for a previously unappreciated, non-canon-
ical role for box C/D snoRNAs as regulators of meta-
bolic stress response pathways in mammalian cells.
INTRODUCTION
Studies in mice and in humans have shown that lipid overload
plays an important role in the pathogenesis of diabetic complica-
tions. In addition to hyperglycemia, free fatty acids and triglycer-
ides are elevated in diabetes due to insulin resistance in both
adipose depots and the liver. Hyperlipidemia leads to excessive
delivery of fatty acid substrates to nonadipose tissues, resulting
in lipid accumulation, which is associated with cellular dysfunc-
tion and cell death through the process of lipotoxicity (Unger,
1995). In diabetes and metabolic syndrome, lipotoxicity contrib-
utes to the pathogenesis of heart failure, renal dysfunction, stea-
tohepatitis, and progressive b cell insufficiency (Angulo, 2002;
Jiang et al., 2005; Sharma et al., 2004; Shimabukuro et al., 1998).
To characterize the cellular mechanisms underlying lipotoxic-
ity, many groups have employed cell culture models in which
growth media is supplemented with excess fatty acids com-
plexed to albumin to achieve free fatty acid levels in the patho-
physiological range. Fibroblasts, myoblasts, pancreatic b cells,
hepatocytes, and endothelial cells demonstrate a time- and
dose-dependent induction of cell death that is characterized
by features of apoptosis (Cacicedo et al., 2005; de Vries et al.,
1997; Listenberger et al., 2001; Maedler et al., 2003; Wei et al.,
2006). This response is relatively specific for saturated free fatty
acids and is augmented by the simultaneous exposure to
elevated glucose concentrations (El-Assaad et al., 2003).While increased triglyceride stores are the sine qua non of lipid
overload in nonadipose cells, in vitro and in vivo studies suggest
that sequestration of excess lipid in triglyceride droplets is cyto-
protective (Listenberger et al., 2003; Liu et al., 2009). However,
the relatively limited capacity for storage of excess fatty acids
in triglyceride droplets in nonadipose cells is rapidly exceeded
in hyperlipidemic states. This is followed by initiation of several
cellular stress response pathways. Fatty acid-induced activation
of NADPH oxidase andmitochondrial dysfunction due to remod-
eling of organelle membranes lead to oxidative stress in a variety
of cell types (Inoguchi et al., 2000; Ostrander et al., 2001). The
observation that anti-oxidants mitigate lipotoxic cell death
supports a central role for oxidative stress in lipotoxicity
(Borradaile et al., 2006b; Listenberger et al., 2001). Excess fatty
acids also induce the endoplasmic reticulum (ER) stress
response pathway, which may be precipitated by oxidative
stress and/or by deleterious remodeling of ER membranes
(Borradaile et al., 2006b; Cnop et al., 2007). Oxidative and ER
stress responses to lipid overload have been demonstrated not
only in cell culture models of lipotoxicity, but also in mouse
models of diabetes (Ozcan et al., 2004). Nonetheless, the precise
molecular mechanisms through which lipids induce these path-
ways remain to be elucidated.
To identify genes critical for the lipotoxic response, we per-
formed a genetic screen in Chinese hamster ovary (CHO) cells
using retroviral promoter trap mutagenesis to create single gene
disruptions and positive selection for survival under lipotoxic
growth conditions. Herein, we describe amutant cell line in which
the promoter trap has disrupted the locus for ribosomal protein
L13a (rpL13a). Unexpectedly, our studies reveal that the portions
of this gene essential for lipotoxicity are three highly conserved
box C/D small nucleolar RNAs (snoRNAs) embedded within the
rpL13a introns, rather than the protein-coding exonic sequences.
Our findings suggest a previously unsuspected role for snoRNAs
in the regulation of metabolic stress in mammalian cells.RESULTS
Disruption of one rpL13a Allele Confers Resistance
to Palmitate-Induced Apoptosis
To identify genes critical for the cellular lipotoxic response, we
performed a genetic screen in CHO cells, with mutagenesis by
transduction with ROSAbgeo retrovirus at low multiplicity of
infection to achieve, on average, one insertion per ten genomes.
Although the integrated provirus contains a complementary DNACell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc. 33
Figure 1. 6F2 Cells Are Resistant to Palmi-
tate-Induced Lipotoxicity
(A) Wild-type (WT) andmutant 6F2 CHO cells were
untreated (UT) or supplemented with 500 mM
palmitate for 48 hr or with 80 nM staurosporine,
2 mM actinomycin D, or 10 mM camptothecin for
24 hr. Cell death was quantified by propidium
iodide (PI) staining and flow cytometry on 104
cells/sample.
(B) WT and 6F2 cells were incubated with
14C-palmitate for 1 min. Uptake of labeled palmi-
tate was assessed by scintillation counting.
(C) WT and 6F2 cells were incubated with
3H-palmitate for 2 hr. 3H2O production as a
measure of fatty acid oxidation was assessed by
scintillation counting.
(D) WT and 6F2 cells were treated with palmitate
for indicated times, or with the ER stress inducers,
tunicamycin (Tm, 2.5 mg/ml), or thapsigargin
(Tg, 1 mM) for 6 hr. grp78 expression was analyzed
by quantitative real-time PCR (qRT-PCR) and
normalized to b-actin expression.
(E)WTand6F2 cells were treatedwith palmitate for
indicated times or with 500 mMH2O2 for 1 hr. ROS
generation was quantified by CM-H2DCFDA (DCF)
labeling and flow cytometry on 104 cells/sample.
(F) WT and 6F2 cells were UT or treated with 2.3 mM H2O2 for 20 hr. Cell death was quantified by PI staining and flow cytometry on 10
4 cells/sample.
All data are expressed as mean ± standard error (SE) for three independent experiments. *p < 0.01 for mutant 6F2 versus WT; n.s., not significant. See also
Figure S1.
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ferase fusion protein, it lacks its own promoter, and thus its tran-
script is expressed only if the retrovirus inserts downstream of an
active promoter and splice donor site. Mutagenized cells that
survived a round of neomycin selection were then treated for
48 hr in media supplemented with a lipotoxic concentration of
palmitate (500 mM) to model pathophysiological states. Under
these conditions, wild-type (WT) cells were killed, but mutant
line 6F2 survived.
Since palmitate-induced cell death occurs through activation
of apoptosis, we first tested whether 6F2 cells retained the ability
to activate these cell death pathways. Using flow cytometry, we
quantified cell death by propidium iodide (PI) staining and
apoptosis by TUNEL staining in parental WT and mutant 6F2
cells treated with palmitate or with three other inducers of
apoptosis (Figure 1A and Figure S1A). Consistent with their isola-
tion in a positive screen under lipotoxic conditions, 6F2 cells
were significantly protected from palmitate-induced cell death
and apoptosis compared to WT cells. However, 6F2 mutants
were not significantly different from WT cells with respect to
cell death or apoptosis induction following treatment with the
other apoptosis inducers. These observations indicate that 6F2
mutant cells have intact cell death pathways, yet they are resis-
tant to apoptosis induced by lipotoxic conditions.
Prior studies suggest that lipotoxic pathways can bemitigated
by activation of pathways through which palmitate is metabo-
lized (Borradaile et al., 2006b; Listenberger et al., 2003). There-
fore, it was possible that the palmitate resistance of 6F2 mutant
cells might have resulted from a defect in fatty acid uptake or
increased ability to metabolize exogenous palmitate. We quanti-
fied cellular uptake of 14C-palmitate in WT and 6F2 cells under
lipotoxic conditions (Figure 1B). The absence of a significant
difference in lipid uptake between 6F2 and WT cells suggests34 Cell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc.that the defect in 6F2 cells is downstream of the cellular lipid
transport machinery. Moreover, b oxidation of exogenous palmi-
tate was not affected by the mutation in 6F2 cells that conferred
resistance to lipotoxicity (Figure 1C). Thus, resistance to lipotox-
icity in the mutant line did not simply result from increased
efficiency of palmitate metabolism.
Previous studies in cultured cells and in mouse models have
implicated ER stress and oxidative stress pathways in the patho-
genesis of lipotoxicity (Ozcan et al., 2004). We hypothesized that
one or both of these stress pathways might be affected in 6F2
cells. We first compared the induction of ER stress in 6F2 and
WT cells after treatment with palmitate. Palmitate treatment in
WT CHO cells resulted in a time-dependent increase in expres-
sion of the protein-folding chaperone grp78 (Figure 1D). This
induction was significantly reduced in mutant 6F2 cells suggest-
ing resistance to ER stress induction. Consistent with this obser-
vation, 6F2 cells also showed delayed and diminished splicing of
XBP-1 pre-mRNA and induction of CHOP expression (Figures
S1BandS1D). However, 6F2andWTcellswere indistinguishable
in these measures following treatment with the chemical ER
stress inducers, tunicamycin and thapsigargin (Figure 1D and
Figures S1C and S1E). Together, these results suggest that 6F2
cells are specifically resistant to palmitate-induced ER stress,
while the general ER stress response machinery remains intact.
ERstress in lipotoxicitymaybe induced, inpart, downstreamof
lipid-induced oxidative stress. To assess palmitate-induced
oxidative stress, we measured levels of intracellular reactive
oxygen species (ROS) using the dihydrofluorescene derivative,
CM-H2DCFDA [6-carboxy-2
0,70-dicholorodihydrofluorescein di-
acetate, di(acetoxymethyl ester) or DCF]. Palmitate treatment
resulted in a time-dependent increase in DCF fluorescence in
WT CHO cells, indicative of an increase in ROS (Figure 1E). This
response was abrogated in 6F2 cells. When ROS production
Figure 2. 6F2 Cells Are Haploinsufficient for
rpL13a
(A) Genomic DNA isolated fromWT and 6F2 mutant
cells was digested with BglII, NcoI, and XbaI and
analyzed by Southern blotting with 32P-labeled
probederivedfromROSAbgeoretroviralsequences.
(B) Upon transduction with the ROSAbgeo retro-
virus, the provirus containing the splice acceptor
(SA), the promoterless b-galactosidase-neomycin
resistance cassette (bgal neoR), and poly-
adenylation (polyA) sequences integrated into the
rpL13a gene in 6F2 cells. Diagram shows resulting
ROSAbgeo fusion transcript containing 50 end of
rpL13a mRNA and bgal neoR sequences and the
endogenous WT rpL13amRNA. Forward (L13a 50)
and reverse (L13a 30) primers for rpL13 and reverse
proviral primer (bgeo 30) are shown with arrows.
(C) PCR was performed with the indicated
primers on cDNA from WT and 6F2 cells to
detect endogenous rpL13a and fusion transcript
expression.
(D) Basal rpL13a RNA expression in WT and 6F2 mutant cells was determined by qRT-PCR and normalized to b-actin expression.
(E) Basal rpL13a protein expression inWTand 6F2mutant cells was determined bywestern blotting and quantifiedby densitometry. A representative blot is shown
for rpL13a and actin loading control.
All data are expressed as mean ± SE for three independent experiments. *p < 0.01 for mutant 6F2 versus WT. See also Figure S2.
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(H2O2), 6F2 cells showed ROS levels that were markedly blunted
compared to WT cells. Furthermore, 6F2 cells were protected
from H2O2-induced cell death when compared to WT cells (Fig-
ure 1F). Together, these data suggest that 6F2 cells are resistant
not only to palmitate-induced oxidative stress, but also to more
generalized oxidative stress induction.
The promoter trap mutagenesis approach we employed facili-
tates identification of the disrupted gene, because after a single
proviral insertion, a unique fusion transcript is generated that
includes the 50 end of the disrupted gene’s messenger RNA
(mRNA) followed by the ROSAbgeo sequence. To confirm the
existence of a single genomic integration, we performed
Southernblot analysis of genomicDNA from6F2cells (Figure 2A).
Labeled probe complementary to proviral sequences hybridized
to only one band in each of three digests of 6F2 DNA, indicating
that there is likely a single proviral integration in the mutant line.
50 RACE (rapid amplification of cDNA ends) revealed the disrup-
ted gene to be ribosomal protein L13a (rpL13a) (Figure 2B). This
integration was confirmed by PCR, which revealed (Figure 2C)
a fusion transcript in 6F2, but not WT cells, and a WT transcript
in both cell types. This suggests that in addition to the trapped
allele, 6F2 cells retain an intact rpL13a allele and thus represent
a model of haploinsufficiency. Consistent with this model, 6F2
cells have an 50% reduction in rpL13a mRNA (Figure 2D) and
protein (Figure 2E) expression compared to WT cells. Of note,
although this protein is a constituent of the large 60S ribosomal
subunit, haploinsufficient 6F2cells showednodecrease inoverall
rates of protein synthesis compared to WT cells under either
normal growth or lipotoxic conditions (Figure S2).
Palmitate Treatment Induces rpL13a snoRNA
Accumulation in CHO Cells
We hypothesized that rpL13a might play a role in palmitate-
induced cell death as a lipotoxicity-inducible gene, as hasbeen the case for disrupted genes in two previously identified
mutants from our laboratory (Borradaile et al., 2006a; Brookheart
et al., 2009). To test for rpL13a induction, we quantified rpL13a
RNA by quantitative real-time PCR (qRT-PCR). mRNA levels
(oligo-dT-primed cDNA) did not increase inWT or 6F2 cells under
lipotoxic conditions (Figure 3A). On the other hand, using total
RNA (random hexamer-primed cDNA) as template, we observed
a 3-fold increase in rpL13a RNA in WT, but not in 6F2 cells under
lipotoxic conditions (Figures 3A and 3B). These findings sug-
gested that in the setting of cellular mechanisms for tight regula-
tion of rpL13amRNA levels, there is specific induction of rpL13a
pre-mRNA under lipotoxic conditions. This prompted us to
examine the noncoding regions of the rpL13a locus.
The genomic structure of rpL13a is highly conserved across
diverse species with respect to intron-exon architecture.
Furthermore, in addition to expected conservation of protein-
coding sequences, all mammalian loci for rpL13a contain four
highly conserved intronic box C/D snoRNAs that are predicted
to be processed during splicing of the rpL13a pre-mRNA tran-
script (Figure 3C) (Nicoloso et al., 1996). These snoRNAs,
U32a, U33, U34, and U35a, are located within introns 2, 4, 5,
and 6, respectively, and range in size from 61–82 nucleotides.
We cloned the rpL13a genomic sequence from CHO cells and
found that U32a, U33, U34, and U35a are conserved 94%,
87%, 91%, and 81%, respectively, between hamster and hu-
mans (Figure 3D). Our RACE results indicated that the proviral
insertion in 6F2 mutant cells is downstream of rpL13a exon 2,
which is predicted not only to disrupt expression of the pro-
cessed rpL13a mRNA, but also expression of the full length
pre-mRNA and the intronic snoRNAs.
Since lipotoxic conditions induced the expression of total RNA
from the rpL13a locus, we hypothesized that rpL13a snoRNAs
would also accumulate under stress conditions. We assessed
the expression of rpL13a-encoded snoRNAs under lipotoxic
conditions by RNase protection assays with 32P-labeled probesCell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc. 35
Figure 3. rpL13a-Encoded Box C/D snoRNAs Are Induced in Palmitate-Treated CHO Cells
(A, B, E, and F) WT and 6F2 cells were untreated (UT) or supplemented with palmitate for 48 hr.
(A and B) cDNA synthesis was primed with either oligo dT (mRNA) or random hexamers (total RNA).
(A) rpL13a expression was analyzed by qRT-PCR, with primers specific to exon 7, and normalized to b-actin expression.
(B) rpL13a expression was analyzed by qRT-PCR, with primers specific to intron 2, and normalized to b-actin expression.
(C) rpL13a gene organization showing location of ROSAbgeo promoter trap insertion and locations of intronic U32a, U33, U34, and U35a snoRNAs.
(D) Comparison of rpL13a snoRNA sequences from mouse (Mm), hamster (Cg), and human (Hs) species. C, D, and D0 box sequences are indicated in boxed,
bolded text. Regions with rRNA antisense homology are underlined. Conserved and nonconserved nucleotides are displayed in lower- and uppercase letters,
respectively.
(E) Small RNA was harvested and used in RNase protection assay with 32P-labeled hamster rpL13a snoRNA probes or miR-16 probe as control.
(F) Autoradiograms from RNase protection experiments as in (E) were quantified by densitometry.
All data are expressed as mean ± SE for three independent experiments. *p < 0.01 for palmitate treated versus untreated. See also Figure S3.
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the microRNA miR-16 did not change under these conditions
and served as a loading control. In WT CHO cells, U32a, U33,
and U35a snoRNAs are expressed at low levels under basal
conditions and increased following palmitate treatment,
whereas U34 was not detected under basal or lipotoxic condi-
tions. In mutant 6F2 cells, induction of U32a, U33, and U35a
was markedly attenuated, consistent with the lack of induction
of total rpL13a RNA (Figures 3A and 3B). We also observed
palmitate induction of U32a, U33, and U35a snoRNAs in WT
C2C12 murine myoblasts, which demonstrate similar sensitivity
to lipotoxic conditions (Figures S3A–S3G). Moreover, these
snoRNAs were induced by saturated fatty acids known to cause
lipotoxicity (myristic, palmitic, and stearic acids), but not by
unsaturated palmitoleic acid and oleic acid, which are well toler-
ated by cells (Figure S3H). Together these findings suggest
a previously undescribed, conserved role for snoRNAs as medi-
ators of lipotoxicity.36 Cell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc.Re-expression of rpL13a Genomic Sequence
Complements 6F2 Cells
To determine whether the rpL13a genomic locus is sufficient to
restore palmitate-sensitivity, we generated stable cell lines in
the mutant 6F2 background. Mutant cells were transfected
with a plasmid containing 4.3 kb from the murine rpL13a
genomic locus, including all eight exons and intervening
introns, expression of which was driven by 1 kb of the endog-
enous rpL13a promoter (gen). As a control, mutant cells were
also transfected with a similar construct in which all four snoR-
NAs were removed, but promoter and exon-intron structure
was otherwise intact (Dsno). Stable clonal gen and Dsno lines
with comparable low basal and palmitate-inducible expression
of total rpL13a RNA were isolated and compared with 6F2 cells
transfected with vector sequences alone (vec) and parental 6F2
cells (–) (Figure 4A). Complementation of 6F2 cells with murine
sequences enabled us to distinguish between expression of
hamster rpL13a sequences from the remaining single allele in
Figure 4. rpL13a Genomic Sequence Containing Box C/D snoRNAs Complements Mutant 6F2 Cells
Mutant 6F2 cells were stably transfectedwith a construct containing genomic rpL13amurine sequence, genomic rpL13amurine sequence with deletion of U32a, U33,
U34,andU35a,or theemptyvector.Clonalcell lineswere isolatedandanalyzeduntreated (UT)or supplementedwithpalmitate for 48hr.Graphsshowuntransfected6F2
cells (–), a stable 6F2 line harboring vector sequences only (vec), and lines expressing genomic (gen1, gen2) or snoRNA-deleted (Dsno1, Dsno2) rpL13a sequences.
(A) cDNA synthesis was primed with random hexamers and rpL13a expression analyzed by qRT-PCR and normalized to b-actin. Primers were chosen from exon
7 sequence that is completely conserved between mouse and hamster.
(B) Small RNA was used in RNase protection assay with murine-specific rpL13a snoRNA probes or mir-16 probe as control.
(C) ROS generation was quantified by DCF labeling and flow cytometry.
(D) cDNA synthesis was primed with oligo dT and grp78 expression analyzed by qRT-PCR and normalized to b-actin.
(E) Cell death was assessed by PI staining and flow cytometry on 104 cells/sample.
All data are expressed as mean ± SE for three independent experiments. *p < 0.01. See also Figure S4.
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sequences, because the RNase protection assays are sensitive
to the small differences between hamster and murine
sequences. We detected palmitate-inducible expression of
murine specific rpL13a snoRNAs U32a, U33, and U35a in cell
lines gen1 and gen2 (Figure 4B). As expected, no expression
of the murine snoRNAs was detected in the Dsno1, Dsno2, or
vec lines. Concomitant with palmitate-inducible expression of
the snoRNAs in gen1 and gen2, we observed significant
increases in palmitate-mediated ROS generation, grp78
mRNA induction, and cell death (Figures 4C–4E). Palmitate-
induced ROS generation, grp78 induction and cell death were
indistinguishable in Dsno1, Dsno2, vec, and untransfected
6F2 cells. These data demonstrate that genomic rpL13a
sequences complement the phenotype in 6F2 cells and
strongly support a specific role for rpL13a-encoded snoRNAs
as mediators of lipotoxicity. Additionally, while transient trans-
fection of 6F2 cells with CMV promoter-driven rpL13a cDNA
and genomic constructs supported higher levels of expression
of the rpL13a mRNA, only the genomic construct restored
palmitate-induced oxidative stress (Figure S4). This further
supports a model in which rpL13a intronic sequences are crit-
ical for lipotoxicity.Directed Knockdown of rpL13a snoRNAs Protects
against Lipotoxicity
To extend these findings to another cell type and to test directly
whether snoRNA expression is necessary for induction of lipo-
toxicity, we nucleofected WT murine C2C12 myoblasts with
phosphorothioate-modified antisense oligos (ASO) comple-
mentary to the 20 nucleotide sequence upstream of the box
D motifs in U32a, U33, and U35a (Ideue et al., 2009). As these
sequences are not represented in the murine rpL13a mRNA
sequence and do not have significant homologies to other
known sequences in the NCBI databases, this approach
provided a means for examining the specific contributions of
each of the snoRNAs. ASO were nucleofected alone and in
combination into cells and compared to a control ASO directed
against green fluorescent protein (GFP) sequence. Nucleo-
fected cells were assayed under basal and lipotoxic (palmi-
tate-supplemented) conditions. Using ASO directed against
each snoRNA, we achieved efficient knockdown of U32a,
U33, and U35a snoRNAs individually without affecting the
expression of the other rpL13a-encoded snoRNAs, indicating
that each ASO preferentially targeted its specific snoRNA
species and not the pre-mRNA (Figure 5A). ASO directed
against U35a did not affect expression of the highly relatedCell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc. 37
Figure 5. Antisense Oligo-Mediated Knockdown of rpL13a-Encoded snoRNAs Protects C2C12 Murine Myoblasts from Palmitate-Induced
and Generalized Oxidative Stress and Cell Death
(A–C) C2C12 myoblasts were nucleofected with the indicated ASOs, designed to specifically target U32a, U33, or U35a snoRNAs or green fluorescent protein
(GFP) as a control. Nucleofected cells were then untreated (UT) or supplemented with palmitate for 24 hr.
(A) Small RNA was used in RNase protection assay with rpL13a snoRNA probes or miR-16 probe as control.
(B) ROS generation was quantified by DCF labeling and flow cytometry.
(C) Cell death was quantified by PI staining and flow cytometry.
(D) After treatment of C2C12 myoblasts with 750 mM H2O2 for 20 hr, small RNA was harvested and used in RNase protection assay as in (A).
(E–G) C2C12 myoblasts were nucleofected with ASOs to target U32a, U33, or U35a snoRNAs or GFP and were then UT or treated with H2O2.
(E) Small RNA was analyzed by RNase protection.
(F) ROS generation was quantified by DCF labeling.
(G) Cell death was quantified by PI staining.
All data are expressed as mean ± SE for three independent experiments. *p < 0.01. See also Figure S5.
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approach (Figure S5A). A cocktail of all three ASO effectively
and simultaneously knocked down palmitate-induced expres-
sion of all three snoRNAs (Figure 5A). This was associated
with a 50% decrease in palmitate-induced ROS and 40%
decrease in palmitate-induced cell death compared to control
cells (Figures 5B and 5C). Knockdown of any one of the
snoRNAs alone was not sufficient to significantly decrease
palmitate-induced ROS generation or PI positivity. As a control,
knockdown of three unrelated box C/D snoRNAs did not
protect against palmitate-induced oxidative stress or death
(Figures S5B–S5D). These findings are consistent with the
palmitate-resistant phenotype we observe in rpL13a-deficient,
palmitate-resistant 6F2 mutant cells. Furthermore, they directly
implicate induction of the three rpL13a-encoded snoRNAs in
palmitate-induced ROS and cell death. Our data support
a model in which the three snoRNAs function in concert to
promote palmitate-induced oxidative stress, since loss of
a single snoRNA alone does not abrogate this response.38 Cell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc.rpL13a snoRNAs Are Mediators of General
Oxidative Stress
In 6F2 cells, genetic disruption of rpL13a not only protects
against lipotoxicity, but also leads to decreased ROS-generation
and cell death in response to H2O2 treatment (Figures 1E and 1F),
suggesting that the rpL13a locus serves as a mediator of gener-
alized oxidative stress. To test whether the rpL13a snoRNAs play
a role in generalized oxidative stress, we treated C2C12 cells
with H2O2 and assessed snoRNA induction. Similar to lipotoxic
conditions, treatment with H2O2 increased U32a, U33, and
U35a snoRNA expression (Figure 5D). ASO-mediated knock-
down of the snoRNAs was effective in blocking H2O2-induced
expression of U32a, U33, and U35a (Figure 5E) and resulted in
a significant decrease in H2O2-induced ROS generation (Fig-
ure 5F) compared to GFP control. Furthermore, snoRNA knock-
down resulted in a 55% reduction in H2O2-induced cell death in
C2C12 cells (Figure 5G). Together, these data implicate rpL13a
snoRNAs in the more general cellular response to oxidative
stress.
Figure 6. U32a, U33, and U35a Accumulate
in the Cytoplasm under Lipotoxic Condi-
tions
(A and B) C2C12 cells were untreated (UT) or
treated with palmitate for 24 hr. Cells were sepa-
rated into cytosolic (CYT) and nuclear (NUC)
fractions by sequential detergent solubilization.
(A) Fractions were analyzed by western blotting for
a cytosolic marker, hsp90, and for a nuclear
marker, lamin B1.
(B) Total RNA was prepared from the fractions and
analyzed for rpL13a snoRNA abundance relative
to 36B4 by qRT-PCR. Graphs show themean ± SE
from a representative experiment (n = 3). *p < 0.05
for palmitate treated versus UT.
(C and D) C2C12 cells were analyzed by in situ
hybridization under basal conditions (UT) and after
24 hr treatment with palmitate (PALM) with
specific snoRNA or control probes (red). Nuclei
were stained with SYTOX Green.
(C) Cells were probed with U3 antisense probe for
known nucleolar snoRNA, control U3 sense probe,
and control rpL13a intron 1 antisense probe.
(D) Control GFP ASO-nucleofected and specific
snoRNA ASO-nucleofected cells were examined
by in situ hybridization with antisense probes for
U32a, U33, and U35a.
Scale bars represent 10 mm. See also Figure S6.
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Box C/D snoRNAs
Canonical box C/D snoRNAs participate in ribonucleoproteins
that localize to nucleoli. In S. cerevisiae and in X. laevis, box
C/D snoRNAs serve as guides that target 20-O-methylation of
ribosomal RNAs (rRNAs) with which they share short stretches
of antisense homology (Kiss-La´szlo´ et al., 1996). Although
they lack some sequence features of canonical 20-O-methyla-
tion guide snoRNAs (internal box C0 sequence not well-
conserved, U33 lacks box D0, rRNA complementarity not
upstream of box D in U35a), U32a, U33, and U35a each contain
10–12 nucleotide stretches of complementarity to rRNA sites of
20-O-methylation (Figure 3D), suggesting a potential role as
guide RNAs for 20-O-methylation of G1328 in 18S and A1511
in 28S (U32a), U1326 in 18S (U33), and C4506 in 28S (U35a)
rRNAs (Nicoloso et al., 1996). We reasoned that if the mecha-
nism of action of snoRNAs U32a, U33, and U35a in lipotoxic
and oxidative stress involved 20-O-methylation of these rRNAs,
modifications of these rRNA sites should be diminished in 6F2
compared to WT cells under metabolic stress conditions
when the snoRNAs are induced in WT cells. However, primer
extension studies showed no differences in the extent of modi-
fication of these rRNA sites between WT and 6F2 cells under
basal or palmitate-treated conditions (Figure S6). These data
indicate that under basal and lipotoxic conditions, either
residual expression of U32a, U33, and U35a in 6F2 cells is suffi-
cient to support these modifications of rRNAs, or this function is
subserved by other molecules in mammalian cells. Furthermore,
at a point in the lipotoxic response at which absence of snoRNA
induction is readily apparent and functionally correlates with
resistance to lipotoxicity in 6F2 cells, there is no corresponding
change in 20-O-methylation of rRNAs.We hypothesized that if U32a, U33, and U35a were involved in
functions other than modification of ribosomal RNAs, then under
lipotoxic stress conditions, they may have a subcellular distribu-
tion distinct from canonical box C/D snoRNAs, which are nucle-
olar. After palmitate treatment of C2C12 cells, we isolated
nuclear and cytosolic RNAs and quantified U32a, U33, and
U35a by qRT-PCR. With palmitate treatment U32a, U33, and
U35a increase in the cytoplasm, whereas levels of these
snoRNAs remain unchanged in the nucleus (Figures 6A and
6B). Accumulation of rpL13a snoRNAs in the cytosol under lipo-
toxic conditions was confirmed by fluorescence in situ hybridiza-
tion. As expected, antisense probe for snoRNA U3 demon-
strated strong nucleolar localization, and this was unaffected
by lipotoxic stress (Figure 6C). Staining for the rpL13a snoRNAs
was perfomed in cells nucleofected with control ASO (GFP) or
with ASO targeting each of the rpL13a snoRNAs. Consistent
with data from RNase protection and qPCR assays, in control
nucleofected cells expression of U32a, U33, and U35a was
low under normal growth conditions and increased under lipo-
toxic conditions (Figure 6D, GFP-nucleofected panels). Promi-
nent staining for each of these snoRNAs was observed in the
cytoplasm, but not nucleoli. The probe for U32a also stains non-
nucleolar regions of the nucleus. Cytoplasmic staining for the
rpL13a snoRNAs under lipotoxic conditions was markedly
diminished when the snoRNAs were depleted by specific
ASOs that target each snoRNA (Figure 6D, U32a, U33, and
U35a ASO-nucleofected panels). Cytoplasmic staining for
U32a, U33, and U35a was also distinct from the nuclear pattern
observed under lipotoxic conditions using a probe specific for
intron 1 (Figure 6C), indicating that the cytosolic distributions
of the rpL13a snoRNAs do not simply reflect localization of the
pre-mRNA. The nuclear staining for U32a resembled the stainingCell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc. 39
Figure 7. rpL13a snoRNAs Are Required for
Oxidative Stress In Vivo
(A) Mice were injected intraperitoneally with lipo-
polysaccharide (LPS), or equivalent volume of
phosphate-buffered saline (PBS) as control, and
liver tissue was harvested 12 hr later. RNA isolated
from livers was used for quantification of rpL13a
snoRNAs (relative to 36B4) or iNOS and Cox2
(relative to actin). The graph shows mean ± SE
from a representative experiment with n = 3 (PBS)
and n = 4 (LPS) animals per group. *p < 0.05 for
LPS versus PBS.
(B–D) Mice were pretreated with three serial doses
of ASOs targeting rpL13a snoRNAs or GFP as
control prior to LPS injection and analysis of liver
tissue.
(B) snoRNA, iNOS, and Cox2 expression in the
liver was quantified as in (A).
(C) Representative images show frozen sections of
liver tissue stained with DHE and parallel sections
in which staining was performed in the presence of
pegylated superoxide dismutase (SOD) as control.
The scale bar represents 100 mm. The graph
shows quantification of fluorescence intensity.
(D) Quantification of protein carbonylation by
western blotting and tissue oxysterols (7-ke-
tocholesterol, 7-keto; 3b,5a,6b-cholestantriol,
triol) 24 hr after LPS. n = 4–6 per group. *p < 0.05
for GFP versus snoRNA knockdown.
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suggesting that this represents detection of the pre-mRNA,
which is not targeted by U32a ASOs. Together our biochemical
and in situ hybridization data support a model in which U32a,
U33 and U35a snoRNAs act in noncanonical roles in the cyto-
plasm during lipotoxic stress.
In Vivo Expression of rpL13a snoRNAs
Our studies of the rpL13a snoRNAs show that these molecules
function in the cellular response to lipotoxic and oxidative stress.
To extend these findings to an in vivo model of oxidative stress,
we examined the expression of rpL13a snoRNAs in a well-estab-
lished model of lipopolysaccharide (LPS)-mediated liver injury
that is characterized by inflammation, steatosis, and oxidative
stress (Bautista and Spitzer, 1990). Compared to saline-injected
control mice, liver tissue from LPS-treated mice showed signifi-
cant upregulation of U32a, U33, and U35a snoRNAs (Figure 7A),
demonstrating that the rpL13a snoRNAs are induced in vivo in
response to metabolic stress.
Based on these findings, we analyzed the effects of loss-of-
function of the rpL13a snoRNAs in the LPS-mediated liver injury
model. To achieve specific knockdown of the snoRNAs in vivo,
mice were treated with three serial intraperitoneal injections of
antisense locked nucleic acid oligonucleotides directed against
each of the three snoRNAs or directed against GFP as a control
prior to LPS injection. Antisense oligonucleotides directed
against the snoRNAs achieved 72%, 84%, and 74% knockdown
of U32a, U33, and U35a, respectively, in liver tissue after LPS
injection without diminishing LPS-induced inflammation (Fig-
ure 7B). Knockdown of the snoRNAs mitigated LPS-induced
oxidative stress as demonstrated by dihydroethidium staining
for superoxide and oxidative damage to liver tissue proteins40 Cell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc.and lipids (Figures 7C and 7D). These findings indicate that
rpL13a snoRNAs are required in vivo for propagation of oxidative
stress.
DISCUSSION
In this study, we combined promoter trap mutagenesis in CHO
cells with a positive selection for survival in the setting of meta-
bolic stress in order to characterize molecular mediators of
lipotoxicity. While the isolation of palmitate-resistant 6F2 cells
identified the rpL13a gene as a mediator of lipotoxicity, the
results of complementation experiments in 6F2 cells and
directed knockdown of snoRNAs in WT murine myoblasts
demonstrate that snoRNAs within this locus, rather than the en-
coded protein, are critical mediators of lipotoxic cell death in
both the hamster and murine species. Consistent with a primary
role for these snoRNAs, lipotoxic stress strongly induces expres-
sion of U32a, U33, and U35a, but has no effect on the steady
state levels of the mRNA encoding rpL13a protein. Our observa-
tions that these snoRNAs are similarly induced following expo-
sure to H2O2, that 6F2 cells are resistant to H2O2-induced ROS
and cell death, and that knockdown of the snoRNAs protects
against H2O2 cytotoxicity together implicate these snoRNAs as
mediators of the general response to oxidative stress. We have
extended these findings in vivo by showing that the rpL13a
snoRNAs are induced in response to LPS-mediated liver injury
and are required for the propagation of oxidative stress in LPS-
treated livers.
The rpL13a locus is highly conserved across species. As
a constituent of the 60S ribosomal subunit, the encoded
rpL13a protein is likely to play an important role in peptide
synthesis. Like many ribosomal proteins, it is predicted to reside
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subunit and may contribute more to regulation of peptide
production than to catalysis of peptide synthesis (Moore and
Steitz, 2003). Thus, it is not entirely surprising that the 6F2
mutant, which is haploinsufficient for rpL13a protein, has rates
of overall protein synthesis that are indistinguishable from WT
cells, a finding consistent with failure of directed knockdown of
rpL13a protein to change global translational activity or alter
translational fidelity (Chaudhuri et al., 2007). Extraribosomal
roles for large and small ribosomal subunit proteins have also
been described, including a role for rpL13a in translational
silencing (Mazumder et al., 2003). However, the function of the
rpL13a locus in lipotoxicity is unlikely to involve this mechanism,
since polysome association of rpL13a and expression from
a reporter construct containing a GAIT element in the 30 untrans-
lated region were unaffected by lipotoxicity (data not shown).
A key observation that facilitated our understanding of the
contributions of the rpL13a locus to lipotoxicity was the extent
of sequence conservation of this gene beyond the protein-
coding exons. Four box C/D snoRNAs, U32a, U33, U34, and
U35a located in rpL13a introns 2, 4, 5, and 6, respectively, are
highly conserved across mammalian species both in terms of
their primary sequence and their position within the locus. While
box C/D snoRNAs function as guides for 20-O-methylation in
yeast (Lowe and Eddy, 1999), the sequences of the U32a, U33,
U34, and U35a snoRNAs and their genomic organization diverge
substantially from yeast to mammals. In mammals, a role in the
modification of ribosomal RNAs has not been demonstrated
for these snoRNAs. We show here in a stable mutant cell line
that decreased basal expression of U32a, U33, and U35a
snoRNAs and loss of palmitate induction of these snoRNAs is
not associated with changes in 20-O-methylation of predicted
rRNA targets, yet is associated with resistance to lipotoxicity.
While it is possible that these snoRNAs contain more than one
functional guide sequence to target multiple substrates including
rRNAs (Cavaille´ et al., 1996; Tycowski et al., 1998), their accumu-
lation in the cytosol during lipotoxicity suggests a nonnucleolar
function for these snoRNAs. An independently transcribed box
C/D snoRNA, U8, has been shown to be exported from the
nucleus (Watkins et al., 2007). The present study provides
evidence for intronic snoRNAs in the cytosol. Our data are
most consistent with amodel in which the rpL13a snoRNAs func-
tion in lipotoxicity and oxidative stress response pathways as
noncanonical box C/D snoRNAs. Our results demonstrate that
U32a, U33, and U35a function coordinately in lipotoxic and
oxidative cellular stress responses in vitro and in propagation
of oxidative stress in vivo. Thus, our study provides evidence
for snoRNA regulation of metabolic stress response pathways.
Increases in rpL13a total RNA are concomitant with induction
of U32a, U33, and U35a, suggesting that induction of these
snoRNAs is regulated, either at a transcriptional level or at the
level of pre-mRNA stabilization. Under basal conditions, mutant
6F2 cells have one half the level of expression of rpL13a mRNA
and protein and diminished U32a, U33, and U35a expression
compared to WT cells, consistent with a model of haploinsuffi-
ciency. However, 6F2 cells fail to induce expression of total
rpL13a RNA and the U32a, U33, and U35a snoRNAs upon lipo-
toxic stress, despite retaining one intact allele for rpL13a.
Although CHO cells are diploid by cytogenetic and chemicalcriteria, a large body of evidence indicates that they are haploid
at many loci by gene expression and functional criteria (Simino-
vitch, 1976). As a consequence, there are many CHO cell
mutants in which mutation of only one of two alleles produces
a null or near null phenotype (e.g., Cao et al., 1996). Furthermore,
evidence is emerging that snoRNA loci, particularly in the brain,
are sites of developmentally programmed epigenetic changes
that affect gene expression (Leung et al., 2009). Thus, the re-
maining allele in mutant 6F2 cells may no longer support tran-
scriptional induction under cellular stress conditions due to
changes in chromatin structure of the rpL13a locus. While lipo-
toxicity and oxidative stress induce rpL13a in total RNA pools
and production of U32a, U33, and U35a, these stresses do not
affect rpL13amRNA levels. This implies that cells have an ability
to regulate levels of rpL13a mRNA tightly, possibly by selective
elimination of the mRNA. Although U34 is not similarly induced
by lipotoxic or oxidative stress in fibroblasts or myoblasts, coor-
dinate induction of all four rpL13a snoRNAs in murine embryonic
stem cells under lipotoxic stress (data not shown) suggests that
there may be cell type-specific or developmentally regulated
mechanisms for snoRNA processing or stability.
Our observations in the LPS-induced model of hepatic tissue
injury confirm that the rpL13a snoRNAs are induced in the setting
of oxidative stress in vivo. Moreover, our in vivo knockdown data
show that these snoRNAs are required for elements of the oxida-
tive stress response, including the production of superoxide,
protein carbonyls, and oxysterols. Because LPS has pleiotropic
effects in vivo and because ASO knockdown in vivo is limited by
liver toxicity, it is not surprising that in vivo knockdown of these
snoRNAs provided only a partial reduction in the oxidative stress
response and did not blunt the release of serum transaminases
(data not shown). In future studies, genetic approaches to loss
of function and/or blunting of additional effector pathways
(e.g., inflammatory signaling) may be required to block liver injury
entirely. Nonetheless, our in vivo knockdown studies show that
the rpL13a snoRNAs are required for the full induction of tissue
oxidative stress in the murine LPS model, thus providing
in vivo evidence for a role of snoRNAs in metabolic stress.
There are a number of mechanisms through which rpL13a
snoRNAs may function in metabolic stress. Although some
snoRNAs serve as substrates for Dicer-mediated cleavage and
function as precursors for miRNA biogenesis (Ender et al.,
2008), our RNase protection analyses of the rpL13a snoRNAs
provided no evidence that U32a, U33, or U35a are processed
to produce smaller microRNAs. Alternatively, noncanonical
snoRNAs may serve as guides in ribonucleoproteins that cata-
lyze chemical modifications of nonribosomal RNA species
through RNA editing, alternative splicing, methylation, or acety-
lation. In mammalian cells, some snoRNAs have been shown to
target small nuclear RNAs and RNA pol II transcripts (Cavaille´
et al., 1996; Tycowski et al., 1998). Two box C/D snoRNAs,
HBII-52 and HBII-85, have been implicated in adenosine-to-ino-
sine editing and/or alternative splicing of the serotonin receptor
5-HT2cR, through a mechanism involving complementarity of
the snoRNA antisense elements to exonic sequence of the sero-
tonin receptor pre-mRNA proximal to a splice junction (Kishore
and Stamm, 2006). Localization of rpL13a snoRNAs in the
cytosol suggests that they could function in regulation of
mRNA translation, possibly through targeted modification orCell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc. 41
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gene expression during the lipotoxic and oxidative stress
responses (Biden et al., 2004; Han et al., 2008; Shenton et al.,
2006), the coordinate function of the rpL13a snoRNAs, and the
possibility that snoRNA-directed modifications of targets may
not be reflected by changes in abundance of those RNAs, iden-
tification of specific targets for each of these snoRNAs will be
a complex task and the subject of future investigations.
Our genetic screen demonstrates that a mutation in a single
gene can render cells resistant not only to lipotoxicity, but also
to generalized oxidative stress. Previous biochemical studies in
diverse cell types have correlated lipotoxic stress with the gener-
ation of ROS (Borradaile et al., 2006a; Inoguchi et al., 2000). Our
study provides evidence of a functional link between the prog-
ress of lipotoxic cell death and the deleterious cellular response
to oxidative stress. While transcriptional, posttranslational and
signaling mechanisms are known to contribute to the cellular
response to oxidative stress (Han et al., 2008; Houstis et al.,
2006), our findings are the first to demonstrate a role for
snoRNAs in the cellular response to this environmental perturba-
tion. The rpL13a snoRNAs may not only play a critical role in the
metabolic stress of lipid overload, but also in the many patho-
physiological processes that involve oxidative stress-induced
cell damage and death.
EXPERIMENTAL PROCEDURES
Additional details of methods are available online in the Supplemental Exper-
imental Procedures.
Cell Culture
CHO-K1 and C2C12 cells were cultured, supplemented with 500 mMpalmitate
(fatty acid to bovine serum albumin [BSA] molar ratio of 2:1), and assayed for
cell death and apoptosis as described (Brookheart et al., 2009; Listenberger
et al., 2001). For reactive oxygen species detection, cells were loaded with
5-(and-6)-chloromethyl-20,70-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2DCFDA, Invitrogen) and analyzed by flow cytometry. Mutants
were generated by transducing CHO cells with the ROSAbgeo retroviral
promoter trap as described (Borradaile et al., 2006a; Friedrich and Soriano,
1991). The endogenous gene disrupted by retroviral insertion was identified
by 50 rapid amplification of cDNA ends (SMART RACE cDNA amplification
kit, Clontech). Cells were assayed for uptake of 14C-palmitate as described
(Brookheart et al., 2009). Palmitate oxidation rates were determined using
[9,10-3H]palmitic acid as described (Djouadi et al., 2003). To assess rates of
protein synthesis, cells were pulse-labeled for with 35S-Cys/Met TCA-precip-
itatable proteins were quantified.
Quantitative Real-Time PCR
TRIzol reagent (Invitrogen) was used to isolate total RNA, and mirVana miRNA
isolation kit (Ambion) was used to isolate small RNA. cDNA synthesis used
SuperScript First-strand Synthesis System (Invitrogen). For snoRNA analyses
stem-loop oligos were used as previously described (Feng et al., 2009).
qRT-PCR was performed using SYBR Green PCR master mixture (Applied Bi-
osystems) and an ABI Prism 7500 Fast Real-Time PCR System. Relative quan-
tification of gene expression was performed using the comparative threshold
method.
snoRNA Probe Synthesis and RNase Digestion
Probes were generated with Megashortscript kit (Ambion). RNA was isolated
from cells and hybridized to 32P-labeled RNA probes (mirVana miRNA Detec-
tion kit), followed by RNase digestion and ethanol precipitation. RNA was
separated by 10% or 15% polyacrylamide electrophoresis and visualized by
autoradiography.42 Cell Metabolism 14, 33–44, July 6, 2011 ª2011 Elsevier Inc.Expression of rpL13a Genomic Constructs
Hamster genomic, murine mRNA, and murine genomic rpL13a sequences
were generated from CHO DNA, C2C12 cDNA, and a murine chromosome
7 BAC clone (RP24-235B15, CHORI), respectively, with Platinum Taq Hi-
Fidelity polymerase (Invitrogen). QuikChange II Site-directed Mutagenesis
Kit (Stratagene) was used to create mutant constructs. Constructs were trans-
fected into 6F2 mutant cells with Lipofectamine 2000 (Invitrogen), followed by
antibiotic selection for stable cell lines.
snoRNA Knockdown In Vitro
20-O-methyl-modified anti-sense oligos (ASOs) were designed to specifically
target murine U32a, U33, U35a, U50, U57, and U60 snoRNA sequences ac-
cording to Ideue et al. (2009) and nucleofected into C2C12myoblasts (Amaxa).
An ASO targeting sequence from GFP was used as a control.
Immunoblot Analyses
Total cell lysates or subcellular fractions isolated by sequential detergent solu-
bilization (Holden and Horton, 2009) were immunoblotted with a polyclonal
rabbit a-hamster rpL13a antibody (1:2000), monoclonal a-actin (Sigma),
monoclonal a-CHOP-10 (Santa Cruz), a-hsp90 (Stressgen), and a-lamin B1
(Abcam) antibodies. Visualization used horseradish peroxidase-conjugated
secondary antibodies (Jackson ImmunoResearch Laboratories) and chemilu-
minescence (PerkinElmer Life Sciences).
Mapping of 20-O-Methyl Modification by Primer Extension
Determination of 20-O-methyl modifications was as described (Lowe and
Eddy, 1999).
In Situ Hybridization of snoRNA Probes
Synthesis, labeling, and hybridization of RNA probes were as described
(Darzacq et al., 2002).
Mouse Model of LPS-Mediated Oxidative Stress and In Vivo snoRNA
Knockdown
Mice were injected intraperitoneally (IP) with LPS (8 mg/kg) or equivalent
volume of PBS and euthanized 12–24 hr later for analysis of liver tissue. For
knockdown experiments, locked nucleic acid (LNA)-modified ASOs (Exiqon)
to specifically target snoRNAs or to target GFP as a control were injected IP
every other day for three doses (2.5 mg/kg of total LNA per injection) prior to
LPS administration. Detection of superoxide was performed on frozen
sections using dihydroethidium (DHE, Invitrogen) and PEG-SOD (Sigma)
(Miller et al., 2008). Quantification of liver protein carbonyls was performed
with OxyBlot Protein Oxidation Detection Kit (Chemicon), and quantification
of liver oxysterols was as described (Porter et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at
doi:10.1016/j.cmet.2011.04.009.
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